The undersigned strongly urge CMMI to delay Ambulatory Specialty Model (ASM)’s launch until all operational and technical infrastructure is available, tested, and ready for the model to start.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
The SUSTAIN 340B Act represents a constructive bipartisan effort to establish clear and durable rules for all stakeholders in the program.
AHA comments on the CMS Preliminary CY 2027 Medicare Clinical Laboratory Fee Schedule Rates and accompanying documents released on Sept. 21, 2026.
The American Hospital Association voices support of the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025 (S. 1974).
AHA provides feedback to the Food and Drug Administration on regulatory considerations for generative artificial intelligence (GenAI)-enabled medical devices.
The American Hospital Association voices support of the 340B Rebate Model Delay Act (H.R. 10770).
AHA Comments to MedPAC on MA Beneficiaries' Post-acute Care Service Utilization.
AHA comments on the bipartisan leadership in introducing the Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act).
AHA Comments on the Department of Homeland Security’s (DHS) proposed fee for H-1B petitions.
AHA comments on the Centers for Medicare & Medicaid Services's proposed rule regarding the indirect hold harmless threshold of healthcare-related taxes.